 Vascular Resistance
"Vascular Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.
| Descriptor ID |
D014655
|
| MeSH Number(s) |
G09.330.380.921
|
| Concept/Terms |
Total Peripheral Resistance- Total Peripheral Resistance
- Peripheral Resistance, Total
- Resistance, Total Peripheral
- Systemic Vascular Resistance
- Resistance, Systemic Vascular
- Vascular Resistance, Systemic
- Peripheral Resistance
- Resistance, Peripheral
|
Below are MeSH descriptors whose meaning is more general than "Vascular Resistance".
Below are MeSH descriptors whose meaning is more specific than "Vascular Resistance".
This graph shows the total number of publications written about "Vascular Resistance" by people in this website by year, and whether "Vascular Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1983 | 0 | 1 | 1 | | 1985 | 0 | 4 | 4 | | 1986 | 1 | 3 | 4 | | 1987 | 1 | 1 | 2 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 3 | 3 | | 1990 | 2 | 0 | 2 | | 1991 | 1 | 2 | 3 | | 1992 | 0 | 1 | 1 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 2 | 2 | | 1995 | 0 | 4 | 4 | | 1996 | 1 | 2 | 3 | | 1997 | 1 | 3 | 4 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 3 | 4 | | 2000 | 0 | 1 | 1 | | 2001 | 2 | 2 | 4 | | 2002 | 1 | 2 | 3 | | 2003 | 0 | 3 | 3 | | 2004 | 1 | 5 | 6 | | 2005 | 0 | 5 | 5 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 3 | 4 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2018 | 0 | 2 | 2 | | 2019 | 2 | 1 | 3 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vascular Resistance" by people in Profiles.
-
Sweatt AJ, Miyagawa K, Rhodes CJ, Taylor S, Del Rosario PA, Hsi A, Haddad F, Spiekerkoetter E, Bental-Roof M, Bland RD, Swietlik EM, Gräf S, Wilkins MR, Morrell NW, Nicolls MR, Rabinovitch M, Zamanian RT. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency. Chest. 2021 10; 160(4):1442-1458.
-
Allan T, Dryer K, Fearon WF, Shah SJ, Blair JEA. Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2019 10; 25(10):843-845.
-
Hoffman GM, Scott JP, Ghanayem NS, Stuth EA, Mitchell ME, Woods RK, Hraska V, Niebler RA, Bertrandt RA, Mussatto KA, Tweddell JS. Identification of Time-Dependent Risks of Hemodynamic States After Stage 1 Norwood Palliation. Ann Thorac Surg. 2020 01; 109(1):155-162.
-
Dunham-Snary KJ, Wu D, Potus F, Sykes EA, Mewburn JD, Charles RL, Eaton P, Sultanian RA, Archer SL. Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction. Circ Res. 2019 06 07; 124(12):1727-1746.
-
Uriel N, Imamura T, Sayer G, Agarwal R, Sims DB, Takayama H, John R, Pagani FD, Naka Y, Sundareswaran KS, Farrar DJ, Jorde UP. High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation. J Card Fail. 2019 Oct; 25(10):777-784.
-
Rose L, Prins KW, Archer SL, Pritzker M, Weir EK, Misialek JR, Thenappan T. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide. J Heart Lung Transplant. 2019 02; 38(2):145-155.
-
Dryer K, Gajjar M, Narang N, Lee M, Paul J, Shah AP, Nathan S, Butler J, Davidson CJ, Fearon WF, Shah SJ, Blair JEA. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018 05 01; 314(5):H1033-H1042.
-
Agarwal R, Gomberg-Maitland M. Physiologic Markers of Exercise as a Potential Screening Tool for the Detection of Pulmonary Hypertension: "a" Few Steps Forward. Chest. 2016 Feb; 149(2):295-297.
-
Bonham CA, Oldham JM, Gomberg-Maitland M, Vij R. Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series. Chest. 2015 Oct; 148(4):1055-1062.
-
Wolfson AM, Steiger N, Gomberg-Maitland M. New pharmacotherapies for pulmonary hypertension: where do they fit in? Curr Hypertens Rep. 2014 Dec; 16(12):496.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|